Tranexamic Acid and its effect on TURP operatio
Not Applicable
- Conditions
- benign hypertrophy of prostate.Hypertrophy (benign) of prostate
- Registration Number
- IRCT2015030111822N5
- Lead Sponsor
- Vice chancellor for Research and Technology, Hamadan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Patients with BPH; that are 50-80 years old. their prostate gland weight was measured by sonography. measuring of Hb, Hct before the surgery. ASA=II. Exclusion criteria: patient disagreement.renal dysfunction .color vision dysfunction .coagulopathy. IHD or arrhythmia .anticoagulant consumption, CVA. Hx of tranexamic acid allergy. Hx of PTE or DVT.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hct. Timepoint: before and 6hr after surgery. Method of measurement: automatic analysor.(cell count).;Hb. Timepoint: before and 6hr after surgery. Method of measurement: automatic analysor.(cell count).;Prostate weight. Timepoint: before the surgery. Method of measurement: by sonography in mg.;Duration of the surgery. Timepoint: after the surgery. Method of measurement: as soon as entering to urinary urethral until foley catheter fixation.;Sergeon satisfaction. Timepoint: after the surgery. Method of measurement: surgeon opinion.;Transfusion. Timepoint: after the surgery. Method of measurement: amount of unit packed cell.;Serum volume during the surgery. Timepoint: after the surgery. Method of measurement: intake serum volume in cc.
- Secondary Outcome Measures
Name Time Method ausea. Timepoint: 6 hr after surgery. Method of measurement: Ask the patient.;Seizure. Timepoint: 6 hr after surgery. Method of measurement: Ask the patient.;Vomiting. Timepoint: 6 hr after surgery. Method of measurement: Ask the patient.